| AAS | Anabolic androgenic steroids |
| AASoln | Antibiotic/antimycotic solution |
| Akt | A member of serine/threonine-specific protein kinase family (also known as protein kinase B; PKB) that plays a pivotal function in controlling the molecular balance between survival and death pathways in cells |
| AR | Androgen receptor |
| ASCs | Adult stem cells |
| Bdn | Boldenone |
| CSCs | Cancer stem cells |
| CD | Cluster of differentiation |
| ECAR | Extracellular acidification rate |
| ERK1/2 | Extracellular signal-regulated protein kinases 1 and 2; also known as p44 mitogen-activated protein (MAP) kinase (a 44-kDa isoform of MAPK) and p42 mitogen-activated protein (MAP) kinase (a 42-kDa isoform of MAPK), respectively |
| ESCs | Embryonic stem cells |
| GPCRC6A | G protein-coupled receptor family C group 6 member A; a novel membrane androgen receptor (mAR) related to the extranuclear action of androgens |
| HA | Hyaluronic acid |
| HepG2 | Human hepatocarcinoma-derived cell lines |
| IGF-I | Insulin-like growth factor-I |
| Klf-4 | Krüppel-like factor-4 (also called gut-enriched Krüppel-like factor or GKLF); an evolutionarily conserved zinc finger-containing transcription factor that regulates diverse cellular processes such as cell growth, proliferation, differentiation, apoptosis, and somatic cell reprogramming |
| mARs | Novel membrane androgen receptors (unrelated to nuclear androgen receptors) that are engaged in a broad spectrum of non-classical, cell surface-initiated androgen actions |
| MSCs | Mesenchymal stem cells |
| mTOR | Mechanistic target of rapamycin (previously known as mammalian target of rapamycin) that represents a family of serine/threonine-specific protein kinases; mammalian target of rapamycin (mTOR) kinase that has been identified as a direct target of the rapamycin-FKBP12 (FK506-binding protein 12 kDa) complex; mTOR kinase is also designated as FK506-binding protein 12-rapamycin complex-associated protein 1 (FRAP1) |
| NANOG | Homeobox-containing transcription factor whose name stems from Celtic/Irish mythical word Tír na nÓg (i.e., Tir Na Nog; The Land of the Ever-Young) |
| NDCs | Nuclear donor cells |
| Ndn | Nandrolone |
| NF-κB | Nuclear factor-κB (nuclear factor kappa-light-chain-enhancer of activated B cells); a pleiotropic inducible transcription factor that occurs in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as cytodifferentiation, cell growth, tumorigenesis, apoptosis, inflammation, and immunity |
| NOD-SCID | Non-obese diabetic/severe combined immunodeficient mouse model |
| OCICs | Ovarian cancer initiating cells |
| OCR | Oxygen consumption rate |
| Oct-4 | Octamer-binding transcription factor-4 (also designated as POU5F1); a member of the family of POU (Pit-Oct-Unc)-domain and homeodomain transcription factors |
| oPSCs | Ovarian putative stem cells |
| OXER1 | G protein-coupled oxo-eicosanoid receptor 1; a receptor of the arachidonic acid metabolite, i.e., 5-oxoeicosatetraenoic acid (5-oxoETE); known as a novel mAR involved in the rapid effects of androgens |
| PCDs | Potentially cancerous derivatives |
| PCNA | Proliferating cell nuclear antigen |
| PCOS | Polycystic ovary syndrome |
| PI3K | Phosphatidylinositol 3-kinase; a downstream kinase activated by receptor tyrosine kinases that generates a series of phosphorylated phosphoinositides, which recruit 3-phosphoinositide-dependent protein kinase-1 (PDPK1) activity to the plasma membrane, leading to activation of Akt |
| poPSCs | Porcine ovarian putative stem cells |
| RIPA | Radioimmunoprecipitation assay buffer |
| Rex1 | Reduced expression gene 1 encoding a DNA-binding transcription factor known as reduced expression protein 1 or zinc finger protein 42 homolog |
| ROS | Reactive oxygen species |
| SCNT | Somatic cell nuclear transfer |
| Sox2 | Sex-determining region Y (SRY)-box 2; a member of the high mobility group (HMG)-box family of DNA-binding transcription factors |
| ZIP9 | Zinc transporter member 9; also designated as solute carrier family 39 member 9 (SLC39A9) or transmembrane zinc-influx transporter (Zrt)- and transmembrane iron-influx transporter (Irt)-like protein (ZIP) 9; represents both zinc (Zn2+)-iron (Fe2+) permease (ZIP) family and a novel membrane androgen receptor (mAR) family related to the extranuclear action of androgens |